Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 112
- 试验地点
- 1
- 主要终点
- Percentage of providers reporting the use of different tumor genetic testing strategies among newly diagnosed endometrial cancer patients
研究概览
简要总结
In order to formulate strategies to improve adherence to best practice guidelines, as well as utilization of novel therapies, investigators must understand current practice patterns surrounding tumor genetic testing in endometrial cancer. The aim is to survey a representative sample of gynecologic oncologists who belong to the society of gynecologic oncology, via an email survey, to better understand current practices surrounding tumor genetic testing as well as determine if there have been any changes to practice since the publication of recent trials on the use of immune-checkpoint inhibitors in endometrial cancer.
详细描述
Primary Objective: Proportion of physicians reporting the use of different tumor genetic testing strategies among newly diagnosed endometrial cancer patients.
Secondary Objectives:
- Explore the use of informed consent in tumor genetic testing in endometrial cancer
- Explore clinician confidence in utilizing tumor genetic testing to guide treatment decisions.
- Explore the impact of recent publications regarding immunotherapy on the use of tumor genetic testing in endometrial cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Member of the Society of Gynecologic Oncology
- •Gynecologic Oncologist or Gynecologic Oncology Fellow-in-Training
排除标准
- 未提供
结局指标
主要结局
Percentage of providers reporting the use of different tumor genetic testing strategies among newly diagnosed endometrial cancer patients
时间窗: 4 months
The primary outcome is to estimate the percentage of providers who report the use of different tumor testing strategies. Investigators will calculate the frequencies of responses to each testing strategy and then compare the percentage of physicians who choose different strategies, using a chi-square or Fisher's exact test.
次要结局
- Number of providers reporting confidence in utilizing tumor genetic testing to guide treatment decisions(4 months)
- Number of providers who change their counseling or testing strategies for endometrial cancer(4 months)
- Frequency of providers using different strategies of informed consent in tumor genetic testing in endometrial cancer(4 months)